Indaptus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Selling, General & Admin	8.76	8.59	5.21	0.94	8.29	7.93	5.14	3.1	2.79	2.61	Upgrade
Research & Development	7.62	6.32	2.52	2.66	26.66	35.4	24.3	10.75	4.82	3.41	Upgrade
Other Operating Expenses	0	0	0	0	12.16	0	0	-0.03	-0.02	-0.23	Upgrade
Operating Expenses	16.38	14.91	7.73	3.6	47.11	43.33	29.44	13.81	7.58	5.78	Upgrade
Operating Income	-16.38	-14.91	-7.73	-3.6	-47.11	-43.33	-29.44	-13.81	-7.58	-5.78	Upgrade
Interest Expense / Income	0	0	0	0	-0.15	0.11	-0.56	0.02	0.23	0.23	Upgrade
Other Expense / Income	-0.96	-0.59	-0.02	-0.02	-	-	-	-0.47	-0.63	0.49	Upgrade
Pretax Income	-15.42	-14.32	-7.71	-3.58	-46.96	-43.44	-28.88	-13.36	-7.18	-6.5	Upgrade
Income Tax	0	0	0	0	0.64	0.1	0.03	0	0	0	Upgrade
Net Income	-15.42	-14.32	-7.71	-3.58	-47.6	-43.54	-28.91	-13.36	-7.18	-6.5	Upgrade
Shares Outstanding (Basic)	8	8	4	2	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	8	8	4	2	0	0	0	-	-	-	Upgrade
Shares Change	1.68%	101.98%	110.35%	360.55%	8.29%	76.63%	54.26%	13.24%	-	-	Upgrade
EPS (Basic)	-1.83	-1.73	-1.89	-1.84	-112.72	-112.00	-131.20	-93.60	-73.60	-94.40	Upgrade
EPS (Diluted)	-1.83	-1.73	-1.89	-1.84	-112.72	-112.00	-131.20	-93.60	-73.60	-94.40	Upgrade
Free Cash Flow	-13.41	-12.91	-10.84	-3.32	-29.97	-43.74	-27.13	-12.49	-9.32	-4.83	Upgrade
Free Cash Flow Per Share	-1.60	-1.56	-2.65	-1.71	-70.97	-112.19	-122.88	-87.26	-73.71	-38.20	Upgrade
EBITDA	-15.42	-14.32	-7.71	-3.58	-46.26	-42.47	-28.61	-13.35	-6.95	-6.27	Upgrade
Depreciation & Amortization	0	0	0	0	0.85	0.86	0.83	0	0	0	Upgrade
EBIT	-15.42	-14.32	-7.71	-3.58	-47.11	-43.33	-29.44	-13.35	-6.95	-6.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).